Masimo Corporation (NASDAQ:MASI) has been given a consensus recommendation of “Hold” by the six research firms that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $86.00.
Several research firms recently weighed in on MASI. Wedbush restated an “outperform” rating and set a $95.00 price target on shares of Masimo Corporation in a research report on Monday, February 27th. Piper Jaffray Companies lowered shares of Masimo Corporation from an “overweight” rating to a “neutral” rating in a research report on Thursday, March 16th. Finally, Zacks Investment Research lowered shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 11th.
In related news, CEO Joe E. Kiani sold 145,841 shares of the stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $102.37, for a total transaction of $14,929,743.17. Following the completion of the transaction, the chief executive officer now owns 165,082 shares in the company, valued at $16,899,444.34. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Joe E. Kiani sold 154,159 shares of the stock in a transaction dated Wednesday, April 26th. The shares were sold at an average price of $99.70, for a total transaction of $15,369,652.30. Following the transaction, the chief executive officer now owns 219,241 shares of the company’s stock, valued at approximately $21,858,327.70. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 562,201 shares of company stock valued at $56,005,386. 16.60% of the stock is owned by company insiders.
Institutional investors have recently modified their holdings of the company. BlackRock Inc. raised its position in shares of Masimo Corporation by 4,676.3% in the first quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock worth $686,789,000 after buying an additional 7,210,051 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Masimo Corporation by 5.9% in the first quarter. Vanguard Group Inc. now owns 4,617,633 shares of the medical equipment provider’s stock worth $430,641,000 after buying an additional 258,719 shares in the last quarter. Janus Capital Management LLC raised its position in shares of Masimo Corporation by 0.5% in the fourth quarter. Janus Capital Management LLC now owns 2,703,291 shares of the medical equipment provider’s stock worth $182,202,000 after buying an additional 13,735 shares in the last quarter. State Street Corp raised its position in shares of Masimo Corporation by 42.8% in the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock worth $130,704,000 after buying an additional 419,767 shares in the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of Masimo Corporation by 45.0% in the first quarter. Acadian Asset Management LLC now owns 1,399,187 shares of the medical equipment provider’s stock worth $130,489,000 after buying an additional 434,389 shares in the last quarter. Hedge funds and other institutional investors own 83.48% of the company’s stock.
Masimo Corporation (MASI) traded up 0.29% on Monday, reaching $91.11. 639,658 shares of the company were exchanged. The company’s 50-day moving average price is $89.56 and its 200-day moving average price is $83.01. The stock has a market capitalization of $4.66 billion, a P/E ratio of 15.47 and a beta of 0.89. Masimo Corporation has a 12-month low of $48.07 and a 12-month high of $104.71.
Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, May 3rd. The medical equipment provider reported $0.82 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.22. The company had revenue of $186.30 million during the quarter, compared to the consensus estimate of $184.14 million. Masimo Corporation had a net margin of 44.86% and a return on equity of 24.19%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.53 earnings per share. Equities research analysts anticipate that Masimo Corporation will post $2.66 earnings per share for the current fiscal year.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2231069/masimo-corporation-masi-given-consensus-rating-of-hold-by-brokerages.html
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.